Skip to content

Assessing Innovative Wireless and Wearable Sensors for Continuous Blood Pressure Measurement in Obese Pregnant Women

Assessing Innovative Wireless and Wearable Sensors for Continuous Blood Pressure Measurement in Obese and Super-obese Pregnant Women

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05790265
Enrollment
20
Registered
2023-03-30
Start date
2023-05-01
Completion date
2023-12-31
Last updated
2023-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Brief summary

This study is a prospective study targeting at least 20 obese and super-obese patients admitted to Labor & Delivery (L&D) for delivery at UNC Medical Center. Patients with clinical indicated radial A-lines either planned or already in-situ will be offered participation. The study will evaluate the accuracy of noninvasive blood pressure measurements with the ANNE One system to blood pressure readings with the radial A-line.

Interventions

DEVICEANNE One

Chest sensor for single lead ECG and finger sensor for pulse oximetry.

Sponsors

University of North Carolina
CollaboratorOTHER
Sibel Health Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>= 18 years old * Ability and willingness to provide written informed consent * Admitted for delivery at UNC Medical Center * BMI of \>= 40 kg/m2 * Clinically indicated radial A-lines either planned or already in-situ prior to delivery

Exclusion criteria

* Skin sensitivity or allergy that precludes placement of ANNE One * Any condition (social or medical) which, in the opinion of the study staff would make any study participation unsafe or complicate data interpretation * Expected delivery within \<= 1 hour of arrival to L&D

Design outcomes

Primary

MeasureTime frameDescription
Mean absolute error (MAE) and standard deviation of blood pressure measurements with ANNE One compared to arterial line8 hoursMean absolute error and standard deviation between the non-invasive blood pressure measurement provided by the device under test and the invasive blood pressure measurement from the arterial line.

Contacts

Primary ContactSarah E Coughlin
sarah.coughlin@sibelhealth.com(224)251-8859

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026